search icon
      blog search icon

      Cybin Stock Price History and Quote Analysis: Insights for Investors

      Cybin Inc.



      -0.03 (-5.44%)

      At Close: 4:00 PM

      Cybin Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      Cybin Stock Price Today

      Cybin Inc. (CYBN) stock declined over -5.40% intraday to trade at $0.5392 a share on AMEX. The stock opened with a gain of 1.75% at $0.58 and touched an intraday high of $0.58, falling -5.40% against the last close of $0.57. The Cybin Inc. in stock market went to a low of $0.53 during the session.

      Cybin Stock Snapshot


      Prev. Close

      120.5 Million

      Market Cap


      Day Low




      Number of Shares


      Day High


      P/E ratio


      EPS (TTM)


      Cash Flow per Share


      Free Float in %


      Book Value



      Cybin Stock Price History Chart


      Contact Details

      100 King Street West
      Toronto, ON M5X 1C9


      Contact #:908 764 8385

      Company Information



      Sales or RevenueN/A

      5Y Sales Change-20.00%

      Fiscal Year EndsMar. 2023



      About Company

      Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.


      Frequently Asked Questions


      What is the current Cybin Inc. (CYBN) stock price?

      Cybin Inc. (AMEX: CYBN) stock price is $0.54 in the last trading session. During the trading session, CYBN stock reached the peak price of $0.58 while $0.53 was the lowest point it dropped to. The percentage change in CYBN stock occurred in the recent session was -5.40% while the dollar amount for the price change in CYBN stock was -$0.03.


      CYBN's industry and sector of operation?

      The AMEX listed CYBN is part of Biotechnology industry that operates in the broader Healthcare sector. Cybin Inc. , a biopharmaceutical company, focuses on developing psychedelic-based therapeutics.


      Who are the executives of CYBN?

      Ms. Leah Gibson
      Vice President of Investor Relations & Strategic Communications
      Mr. Eric So L.L.B., LLB
      Co-Founder, Pres & Executive Chairman
      Mr. Douglas L. Drysdale
      Chief Executive Officer
      Mr. Gabriel Fahel
      Chief Legal Officer & Corporation Sec.


      How CYBN did perform over past 52-week?

      CYBN's closing price is 0.20% higher than its 52-week low of $0.21 where as its distance from 52-week high of $0.715 is -0.72%.


      How many employees does CYBN have?

      Number of CYBN employees currently stands at N/A. CYBN operates from 100 King Street West, Toronto, ON M5X 1C9, CA.


      Link for CYBN official website?

      Official Website of CYBN is:


      How do I contact CYBN?

      CYBN could be contacted at phone #908 764 8385 and can also be accessed through its website. CYBN operates from 100 King Street West, Toronto, ON M5X 1C9, CA.


      How many shares of CYBN are traded daily?

      CYBN stock volume for the day was 3117148.00 shares. The average number of CYBN shares traded daily for last 3 months was 4.22 Million.


      What is the market cap of CYBN currently?

      The market value of CYBN currently stands at $120.5 Million with its latest stock price at $0.54 and N/A of its shares outstanding.